BioPharma Credit PLC (BPCR)

Profile

https://www.bpcruk.com

BioPharma Credit PLC is a closed-ended investment company that provides investors with exposure to the fast-growing life sciences industry through a diversified portfolio of loans and other instruments backed by royalties or cash flows from approved life sciences products. Its primary objective is to generate predictable income for shareholders over the long term, targeting an annual dividend yield of around 7% and a net total return on NAV of 8-9% per annum in the medium term. Managed by Pharmakon Advisors, LP, founded in 2009 with a track record of committing US$10 billion across 62 transactions, the fund leverages deep expertise in healthcare finance to source, analyze, and structure investments. Key portfolio holdings include loans to companies like Collegium Pharmaceutical Inc., Insmed Inc., and BioCryst Pharmaceuticals Inc., predominantly in the U.S. healthcare sector. With quarterly dividends, total assets exceeding £1.1 billion, and a focus on income stability, BioPharma Credit PLC plays a vital role in offering specialized debt financing to biopharma firms while delivering income-oriented opportunities in the investment trust market.